Possible New Target Drug For Multiple Sclerosis Treatment:

A new study shows that blocking a molecule that disrupts the immune system led to 50% reduction of multiple sclerosis in a mouse model of the disease.In their paper the researchers describe promising results in lab tests and a mouse model of the disease where they blocked MCAM. They say a drug For Multiple Sclerosis that does this in humans could delay onset of multiple sclerosis and significantly slow its progression.

Lead author Alexandre Prat, a neurosciences professor at Montreal, says:”We believe we have identified the first therapy that will impact the quality of life of people with multiple sclerosis by significantly reducing the disability and the disease’s progression.”There is no cure for multiple sclerosis (MS), a progressive, disabling neurological disease that leads to paralysis, loss of vision, numbness and difficulty with balance and walking.

1 2 3 4 5
Share.

Comments are closed.